Large-scale testing (Phase 3)Study completedNCT02606461What this trial is testingSelinexor in Advanced LiposarcomaWho this might be right forDedifferentiated Liposarcoma Karyopharm Therapeutics Inc 342
Testing effectiveness (Phase 2)Looking for participantsNCT06389799What this trial is testingA Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma (PERELI)Who this might be right forDedifferentiated Liposarcoma Lund University Hospital 33
Not applicableStudy completedNCT04512495What this trial is testingCirculating " Cancer Cells / Macrophage " HYbrid Cells in Patients With Sarcoma?Who this might be right forSarcoma Institut Claudius Regaud 60
Large-scale testing (Phase 3)Active Not RecruitingNCT04967521What this trial is testingSARC041: Study of Abemaciclib Versus Placebo in Patients with Advanced Dedifferentiated LiposarcomaWho this might be right forAdvanced Dedifferentiated Liposarcoma Sarcoma Alliance for Research through Collaboration 108
Testing effectiveness (Phase 2)UnknownNCT02571829What this trial is testingA Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated LiposarcomaWho this might be right forLiposarcomaSoft Tissue Sarcoma Hadassah Medical Organization 30
Testing effectiveness (Phase 2)Looking for participantsNCT05944224What this trial is testingEfficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab in Patients With Advanced Solid Tumors.Who this might be right forAdvanced Solid Tumors Shanghai Pharmaceuticals Holding Co., Ltd 63
Testing effectiveness (Phase 2)Active Not RecruitingNCT05694871What this trial is testingTesting the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated LiposarcomaWho this might be right forAdvanced Dedifferentiated LiposarcomaLocally Advanced Dedifferentiated LiposarcomaMetastatic Dedifferentiated Liposarcoma+3 more Alliance for Clinical Trials in Oncology 77
Early research (Phase 1)Study completedNCT04242238What this trial is testingStudy of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic SarcomasWho this might be right forSarcomaAdvanced SarcomaHigh Grade Sarcoma+4 more Memorial Sloan Kettering Cancer Center 32
Testing effectiveness (Phase 2)Ended earlyNCT05116683What this trial is testingATX-101 in Advanced Dedifferentiated Liposarcoma and LeiomyosarcomaWho this might be right forLeiomyosarcomaLiposarcoma Benjamin Izar 4
Large-scale testing (Phase 3)Study completedNCT06058793What this trial is testingBrightline-4: A Study to Test How Well Brigimadlin is Tolerated by People With a Type of Cancer Called Dedifferentiated LiposarcomaWho this might be right forLiposarcoma, Dedifferentiated Boehringer Ingelheim 138
Early research (Phase 1)Looking for participantsNCT05711615What this trial is testingTesting Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced SarcomaWho this might be right forMetastatic Dedifferentiated LiposarcomaMetastatic LeiomyosarcomaMetastatic Myxofibrosarcoma+9 more National Cancer Institute (NCI) 30
Large-scale testing (Phase 3)Ended earlyNCT04979442What this trial is testingTreatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated LiposarcomaWho this might be right forDedifferentiated Liposarcoma Rain Oncology Inc 175
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07741877What this trial is testingLifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue SarcomaWho this might be right forSarcomaSoft Tissue Sarcoma (STS)Advanced Soft Tissue Sarcoma+2 more Iovance Biotherapeutics, Inc. 80
Testing effectiveness (Phase 2)Ended earlyNCT05580588What this trial is testingOpen-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic LiposarcomasWho this might be right forLiposarcoma, Dedifferentiated Shanghai Pharma Biotherapeutics USA Inc. 14
Testing effectiveness (Phase 2)UnknownNCT03651375What this trial is testingHypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk WallWho this might be right forSarcomaFibrosarcomaLeiomyosarcoma+14 more Maria Sklodowska-Curie National Research Institute of Oncology 46
Testing effectiveness (Phase 2)Looking for participantsNCT06498648What this trial is testingTesting the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue SarcomaWho this might be right forAdvanced Dedifferentiated LiposarcomaAdvanced LeiomyosarcomaAdvanced Soft Tissue Sarcoma+5 more National Cancer Institute (NCI) 74
Large-scale testing (Phase 3)Study completedNCT05218499What this trial is testingBrightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated LiposarcomaWho this might be right forLiposarcoma, Dedifferentiated Boehringer Ingelheim 400
Early research (Phase 1)Ended earlyNCT03604783What this trial is testingPhase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsSarcomaEwing Sarcoma+2 more Sumitomo Pharma America, Inc. 74
Early research (Phase 1)Active Not RecruitingNCT04420975What this trial is testingNivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue SarcomaWho this might be right forLeiomyosarcomaMalignant Peripheral Nerve Sheath TumorMyxofibrosarcoma+27 more Jonsson Comprehensive Cancer Center 14
Testing effectiveness (Phase 2)Looking for participantsNCT06578624What this trial is testingSafety and Preliminary Efficacy of SA53-OS in Patients With Locally Advanced or Metastatic Solid TumorsWho this might be right forSolid Tumor Lamassu Bio Inc 70